Unlock instant, AI-driven research and patent intelligence for your innovation.

Nanoparticle formulation of amoxicillin

A nanoparticle, amoxicillin technology, applied in the field of amoxicillin nanoparticle formulations, can solve the problems of inability to achieve effective antimicrobial concentration, short residence time, etc.

Inactive Publication Date: 2015-04-29
SAN HEH PHARMA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

One reason for the incomplete eradication of H. pylori may be the short residence time of the dosage form in the stomach, whereby effective antimicrobial concentrations cannot be achieved in the gastric mucus layer or epithelial cell surface where H. pylori is present
Another reason may be that amoxicillin is degraded in gastric acid

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nanoparticle formulation of amoxicillin
  • Nanoparticle formulation of amoxicillin
  • Nanoparticle formulation of amoxicillin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Embodiment 1. Preparation of amoxicillin nanoparticles

[0051] Glucosamine (10 mg from Sigma-Aldrich) was dissolved in water (1 mL) along with amoxicillin (3 mg from Sigma-Aldrich) at room temperature. If the polyglucosamine used is not completely water soluble, add sufficient amount of acetic acid (0.1%-2%) to increase water solubility. The anionic surfactant dioctyl sodium sulfosuccinate was then added to the solution with moderate stirring to a final concentration of 5% w / v and mineral or vegetable oil to a final concentration >75% v / v. The polyglucosamine solution is not miscible with oil and the surfactant acts to stabilize the polyglucosamine nanoparticles. Glutaraldehyde (from Alfa-Aesar) was then added to the mixture to a final concentration of 5%, followed by immediate mixing for 30 minutes to form an emulsification. During emulsification, crosslinking occurs and nanoparticles are formed. When the reaction had ceased, the particles were separated from the s...

Embodiment 2

[0052] Example 2. Nanoparticle Characterization

[0053]The nanoparticles of Example 1 were resuspended in water at a concentration of 1 mg / mL. The particle size and particle size distribution were measured by dynamic light scattering (DLS) using a Malvern Zetasizer (ZEN 3600). To further characterize the morphology, a drop of the nanoparticle suspension was placed on a silica wafer and then air dried overnight. The wafer with the dried sample on it was then coated with chromium and imaged by scanning electron microscopy (SEM).

[0054] Such as figure 2 The average hydrodynamic diameter of the particles is 324.6 nm and the polydispersity index (polydispersity index, PDI) is 0.2 ( figure 2 A). According to SEM, the dry powder exhibits particle morphology with an average diameter of about 300 nm, which is consistent with DLS measurements ( figure 2 B) Consistent.

Embodiment 3

[0055] Embodiment 3. Determination of amoxicillin loading rate

[0056] To measure the drug loading ratio (weight of drug / total weight of nanoparticles), amoxicillin-loaded nanoparticles were formulated following the same procedure described in Example 1, but using different initial drug amounts of 0.1, 1, 2.5 or 5 mg . 1 mg of dry nanoparticles were suspended using 15 mL of water. The suspension was stirred vigorously at 4°C for 12 hours to completely release the loaded drug. The suspension was then filtered through an Amicon filter tube with a molecular weight cutoff of 10 kDa. The amoxicillin concentration in the filtrate was measured and the drug loading was calculated.

[0057] Such as image 3 As shown in , the amoxicillin loading rate in nanoparticles increases with the initial concentration of amoxicillin. When the input concentration of amoxicillin was 0.1, 1, 2.5 and 5 mg / mL, the corresponding loading rates were determined to be 3.9%, 6.9%, 14.2% and 24.1%, resp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
The average diameteraaaaaaaaaa
The average diameteraaaaaaaaaa
The average diameteraaaaaaaaaa
Login to View More

Abstract

The present invention is directed to nanoparticles comprising crosslinked chitosan and amoxicillin, wherein amoxicillin is entrapped by the crosslinked chitosan. The nanoparticles have an average diameter of 100-600 nm, and the entrapped amoxicillin is at least 5% (w / w) of the total weight nanoparticles. The nanoparticles when orally taken have a longer residence time in the stomach than that of free amoxicillin or microspheres having micron sizes. The present invention also provides a process for preparing the nanoparticles. The present invention further provides a method of treating bacterial infection by orally administering to a subject the nanoparticles of the present invention, in an amount effective to treat bacterial infection.

Description

technical field [0001] The present invention relates to a pharmaceutical composition comprising nanoparticles, wherein the nanoparticles comprise cross-linked polyglucosamine coated with amoxicillin. The present invention also relates to a method of using the pharmaceutical composition to treat bacterial infection. Background technique [0002] Amoxicillin is a semi-synthetic orally absorbed broad-spectrum antibiotic. Chemically, it is (2S,5R,6R)-6-[(R)-(-)-2-amino-2-(p-hydroxyphenyl)acetamido]-3,3-dimethyl- 7-oxo-4-thio-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate. Amoxicillin is widely used in combination with a second antibiotic and an acid inhibitor in the standard eradication therapy of gastric and duodenal ulcers associated with Helicobacter pylori infection. H. pylori, a prevalent human-specific pathogen, is the causative agent in chronic active gastritis, gastric and duodenal ulcers, and gastric adenocarcinoma. Treatment of H. pylori remains a challeng...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/43A61K47/36A61K9/14A61P31/04A61P1/04
CPCY02A50/30
Inventor 高巍伟陈昱祯
Owner SAN HEH PHARMA